Literature DB >> 26604192

Chemotherapy at end-of-life: an integration of oncology and palliative team.

Wing-lok Chan1, Ka-on Lam2, Wai-kwan Siu3, Kwok-keung Yuen3.   

Abstract

Palliative chemotherapy is increasingly used in cancer patients near end of life. With the development of newer anticancer agents which have less side effects and higher expected efficacy, the decision on palliative chemotherapy in patients near end of life is complex. This article illustrates how oncologist and palliative care physicians can work together effectively. This article also gives an overview about the risks of palliative chemotherapy near end of life, patients' and physicians' perspectives in choosing the aggressive treatment and describes what an oncologist should do when facing this challenging situation.

Entities:  

Keywords:  Chemotherapy; Communication; Palliative care; Terminal care

Mesh:

Substances:

Year:  2015        PMID: 26604192     DOI: 10.1007/s00520-015-3031-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  31 in total

1.  Resource utilization for ovarian cancer patients at the end of life: how much is too much?

Authors:  Sharyn N Lewin; Barbara M Buttin; Matthew A Powell; Randall K Gibb; Janet S Rader; David G Mutch; Thomas J Herzog
Journal:  Gynecol Oncol       Date:  2005-09-02       Impact factor: 5.482

2.  Independent validation of the modified prognosis palliative care study predictor models in three palliative care settings.

Authors:  Mika Baba; Isseki Maeda; Tatsuya Morita; Takayuki Hisanaga; Tatsuhiko Ishihara; Tomoyuki Iwashita; Keisuke Kaneishi; Shohei Kawagoe; Toshiyuki Kuriyama; Takashi Maeda; Ichiro Mori; Nobuhisa Nakajima; Tomohiro Nishi; Hiroki Sakurai; Satofumi Shimoyama; Takuya Shinjo; Hiroto Shirayama; Takeshi Yamada; Shigeki Ono; Taketoshi Ozawa; Ryo Yamamoto; Satoru Tsuneto
Journal:  J Pain Symptom Manage       Date:  2014-12-12       Impact factor: 3.612

3.  Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale.

Authors:  Rong-Bin Chuang; Wen-Yu Hu; Tai-Yuan Chiu; Ching-Yu Chen
Journal:  J Pain Symptom Manage       Date:  2004-08       Impact factor: 3.612

Review 4.  A systematic review of physicians' survival predictions in terminally ill cancer patients.

Authors:  Paul Glare; Kiran Virik; Mark Jones; Malcolm Hudson; Steffen Eychmuller; John Simes; Nicholas Christakis
Journal:  BMJ       Date:  2003-07-26

5.  Chemotherapy use among Medicare beneficiaries at the end of life.

Authors:  Ezekiel J Emanuel; Yinong Young-Xu; Norman G Levinsky; Gail Gazelle; Olga Saynina; Arlene S Ash
Journal:  Ann Intern Med       Date:  2003-04-15       Impact factor: 25.391

6.  Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis.

Authors:  H S Kim; H J Kim; S Y Kim; T Y Kim; K W Lee; S K Baek; T Y Kim; M H Ryu; B H Nam; D Y Zang
Journal:  Ann Oncol       Date:  2013-08-13       Impact factor: 32.976

7.  Comparing hospice and nonhospice patient survival among patients who die within a three-year window.

Authors:  Stephen R Connor; Bruce Pyenson; Kathryn Fitch; Carol Spence; Kosuke Iwasaki
Journal:  J Pain Symptom Manage       Date:  2007-03       Impact factor: 3.612

8.  Cancer patients' perceptions of their disease and its treatment.

Authors:  W J Mackillop; W E Stewart; A D Ginsburg; S S Stewart
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

9.  Trends in receiving chemotherapy for advanced cancer patients at the end of life.

Authors:  Hee Seung Lee; Kyeong Hyeon Chun; Dochang Moon; Hahn Kyu Yeon; Sanghoon Lee; SooHyeon Lee
Journal:  BMC Palliat Care       Date:  2015-03-13       Impact factor: 3.234

10.  Cancer chemotherapy near the end of life: the time has come to set guidelines for its appropriate use.

Authors:  Andrea Angelo Martoni; Stephan Tanneberger; Vita Mutri
Journal:  Tumori       Date:  2007 Sep-Oct
View more
  7 in total

1.  A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study.

Authors:  Brice Chanez; François Bertucci; Marine Gilabert; Anne Madroszyk; Frédérique Rousseau; Delphine Perrot; Patrice Viens; Jean-Luc Raoul
Journal:  Support Care Cancer       Date:  2017-03-28       Impact factor: 3.603

2.  End-of-life care in cancer patients: how much drug therapy and how much palliative care? Record linkage study in Northern Italy.

Authors:  Giulio Formoso; Massimiliano Marino; Monica Guberti; Roberto Giuseppe Grilli
Journal:  BMJ Open       Date:  2022-05-06       Impact factor: 3.006

3.  Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer.

Authors:  Carsten Nieder; Terje Tollåli; Ellinor Haukland; Anne Reigstad; Liv Randi Flatøy; Kirsten Engljähringer
Journal:  Support Care Cancer       Date:  2016-05-21       Impact factor: 3.603

4.  Impact of self-decision to stop cancer treatment on advanced genitourinary cancer patients.

Authors:  Hisato Kobayashi; Katsuki Tsuchiyama; Minekatsu Taga; Takahiro Tokunaga; Hideaki Ito; Osamu Yokoyama
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

5.  Impact on place of death in cancer patients: a causal exploration in southern Switzerland.

Authors:  Heidi Kern; Giorgio Corani; David Huber; Nicola Vermes; Marco Zaffalon; Marco Varini; Claudia Wenzel; André Fringer
Journal:  BMC Palliat Care       Date:  2020-10-15       Impact factor: 3.234

6.  Chemotherapy use and quality of life in cancer patients at the end of life: an integrative review.

Authors:  Elham Akhlaghi; Rebecca H Lehto; Mohsen Torabikhah; Hamid Sharif Nia; Ahmad Taheri; Ehsan Zaboli; Ameneh Yaghoobzadeh
Journal:  Health Qual Life Outcomes       Date:  2020-10-07       Impact factor: 3.186

7.  Knowledge and use of prognostic scales by oncologists and palliative care physicians in adult patients with advanced cancer: A national survey (ONCOPRONO study).

Authors:  Raphaëlle Dantigny; Fiona Ecarnot; Guillaume Economos; Elise Perceau-Chambard; Stéphane Sanchez; Cécile Barbaret
Journal:  Cancer Med       Date:  2021-12-24       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.